Literature DB >> 10180650

The iterative use of economic evaluation as part of the process of health technology assessment.

M Sculpher1, M Drummond, M Buxton.   

Abstract

The economic evaluation of health care technologies has a key role within the new National Health Service health technology assessment process. There has, however, been little discussion of the best way of combining economic and clinical research. Economic evaluation should be iterative, generating progressively firmer estimates of cost-effectiveness and helping to maximise the efficiency of health care R&D. Here, four stages of economic analysis are suggested, starting with stage I when the basic clinical science is complete, and finishing with stage IV analysis to generalise the results of earlier studies to routine clinical practice.

Entities:  

Mesh:

Year:  1997        PMID: 10180650     DOI: 10.1177/135581969700200107

Source DB:  PubMed          Journal:  J Health Serv Res Policy        ISSN: 1355-8196


  47 in total

Review 1.  Design, analysis and presentation of multinational economic studies: the need for guidance.

Authors:  Francis Pang
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 2.  Modelling in health economic evaluation. What is its place? What is its value?

Authors:  A Brennan; R Akehurst
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 3.  Handling uncertainty in cost-effectiveness models.

Authors:  A H Briggs
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 4.  Testing the validity of cost-effectiveness models.

Authors:  C McCabe; S Dixon
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 5.  An introduction to Markov modelling for economic evaluation.

Authors:  A Briggs; M Sculpher
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

Review 6.  Common errors and controversies in pharmacoeconomic analyses.

Authors:  S Byford; S Palmer
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

Review 7.  Living in dressings and bandages: findings from workshops with people with Epidermolysis bullosa.

Authors:  Patricia Grocott; Rebecca Blackwell; Heather Weir; Elizabeth Pillay
Journal:  Int Wound J       Date:  2012-04-04       Impact factor: 3.315

Review 8.  The effect of pharmacoeconomics on company research and development decisions.

Authors:  H Grabowski
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

9.  Keeping pace with new technologies: systems needed to identify and evaluate them.

Authors:  A Stevens; R Milne; R Lilford; J Gabbay
Journal:  BMJ       Date:  1999-11-13

10.  Cost-effectiveness of new tests to diagnose and treat coronary heart disease.

Authors:  Leslee J Shaw; Allen J Taylor; Patrick G O'Malley
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.